Curasight
Curasight to present at Redeye Fight Cancer Seminar
REG
The presentation will include an update on the momentum and business progress made by the company and look ahead at the coming news flow for the new year. Management will give an overall update on the company's pipeline based on the proprietary uPAR theranostics platform and focused on diagnosing and treating brain and prostate cancer.
The presentation will be webcasted live 15:05-15:25 (CET), Thursday January 19, 2023.
For more information - please click here
| Datum | 2023-01-16, kl 11:03 |
| Källa | Cision |
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.
Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.